’Miracle’ Young Blood Infusion Treatments Unproven, Potentially Harmful: FDA

But these expensive "fountain of youth" therapies are unproven and potentially unsafe, the U.S. Food and Drug Administration warned on Tuesday.

"Simply put, we're concerned that some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies," FDA Commissioner Dr. Scott Gottlieb said in an agency news release. "Such treatments have no proven clinical benefits for the uses for which these clinics are advertising them and are potentially harmful."

According to the FDA, the use of plasma infusion therapies is on the rise across the United States, often costing thousands of dollars per treatment. The service is being offered by businesses in many states to allegedly treat conditions ranging from normal aging and memory loss to serious disorders such as dementia, Parkinson's disease, multiple sclerosis, Alzheimer's disease, heart disease and post-traumatic stress disorder (PTSD).

Plasma -- the liquid portion of blood -- contains proteins that help clot blood and can be used to treat bleeding and clotting problems. Plasma can benefit patients with severe injuries and those whose blood can't clot due to medications or certain illnesses.

But even under such approved uses, plasma carries risks that include allergic reactions, transfusion-associated circulatory overload, transfusion-related acute lung injury and infectious disease transmission, the FDA said.

"We have significant public health concerns about the promotion and use of plasma for these purposes," Gottlieb said. "There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat, or prevent these conditions, and there are risks associated with the use of any plasma product.

"Treatments using plasma from young donors have not gone through the rigorous testing that the FDA normally requires in order to confirm the therapeutic benefit of a product and to ensure its safety," he explained. "As a result, the reported uses of these products should not be assumed to be safe or effective."

In one example, HuffPost conducted its own investigation into Ambrosia, a startup company offering young plasma services it claims can ease a wide range of ailments.

Jesse Karmazin, Ambrosia's 34-year-old founder, said he was charging customers in multiple states $12,000 for treatments during which they received 2 liters of young plasma.

According to HuffPost, Karmazin said he didn't feel FDA approval of his own study of the merits of young plasma therapy was necessary -- and the results of the study have never been released.

Nevertheless, Karmazin told the U.K. newspaper The Times, "I'm not really in the camp of saying this will provide immortality, but I think it comes pretty close."

But the FDA believes that as with many experimental procedures, it's "buyer beware" when it comes to plasma infusions.

The agency's advice: Anyone considering using plasma for these unapproved uses should talk with their doctor first.

More information

The American Red Cross explains types of blood donations.

Source: https://www.drugs.com/news/miracle-young-blood-infusion-treatments-unproven-potentially-harmful-fda-80539.html?utm_source=ddc&utm_medium=rss&utm_campaign=%27Miracle%27+Young+Blood+Infusion+Treatments+Unproven%2C+Potentially+Harmful%3A+FDA

Ed's Guide to Alternative Therapies

The ten most frequently recommended dietary supplements were biotin, vanadium, chromium, vitamin B6, vitamin C, vitamin E, zinc, selenium, alpha-lipoic acid, and surveillance of Low-Risk Prostate Cancer Tripled fructo-oligosaccharides." The reviewers felt some of these might help at least some. In addition, oxygen is a respiratory metabolite: ;too little has serious metabolic consequences and too much can cause metabolic fatigue. On top of that, I immediately felt worse. The Beverly Hills Center for Hyperbaric Medicine is nationally recognized for its expert clinical care in the area of Hyperbaric Medicine. The group concluded: Future studies evaluating the effects of Iscador should focus on a transparent design and description of endpoints in order to provide greater insight into a treatment often being depicted as ineffective, but highly valued by cancer patients. Treatment for...

Several peer-reviewed scientific articles have suggested value as a neuroprotective agent in stroke, Huntington's, and macular degeneration of the eye. Until the age of three, Gracie's Mitochondrial Disorder meant that life was mainly spent in hospitals. Recognition of the benefit of hbot for difficult cases has moved the use of hbot from treatment of last resort to an important part of primary treatments. Stoller,.D.,.A.A.P., Medical Director Conditions Treated: Acute Retinal Artery Occlusion; discrepancies in Opioid Rx Tied to Overdose Deaths aids; Autism; Cerebral Palsy; Chronic Fatigue Syndrome (CFS Colitis; Diabetic Retinopathy; Head Injury (Cerebral Edema/Coma Lyme Disease; Migraine Cluster Headaches; Multiple Sclerosis (MS Plastic/Reconstructive Surgery (Preparation and Recovery Sickle.